Loading...
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics
The rapid growth of COVID-19 cases is causing an increasing death toll and also paralyzing the world economy. De novo drug discovery takes years to move from idea and/or pre-clinic to market, and it is not a short-term solution for the current SARS-CoV-2 pandemic. Drug repurposing is perhaps the onl...
Na minha lista:
| Udgivet i: | RSC Med Chem |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
RSC
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130630/ https://ncbi.nlm.nih.gov/pubmed/34041486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0md00367k |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|